-
公开(公告)号:US07741323B2
公开(公告)日:2010-06-22
申请号:US10599911
申请日:2005-04-13
申请人: Hyae Gyeong Cheon , Sung-Eun Yoo , Sung Soo Kim , Sung-Don Yang , Kwang-Rok Kim , Sang Dal Rhee , Jin Hee Ahn , Seung Kyu Kang , Won Hoon Jung , Sung Dae Park , Nam Gee Kim , Jang Hyuk Lee , Sun Chul Huh , Jae Mok Lee , Seog Beom Song , Soon Ji Kwon , Jong Hoon Kim , Jeong-Hyung Lee , Seung Jun Kim
发明人: Hyae Gyeong Cheon , Sung-Eun Yoo , Sung Soo Kim , Sung-Don Yang , Kwang-Rok Kim , Sang Dal Rhee , Jin Hee Ahn , Seung Kyu Kang , Won Hoon Jung , Sung Dae Park , Nam Gee Kim , Jang Hyuk Lee , Sun Chul Huh , Jae Mok Lee , Seog Beom Song , Soon Ji Kwon , Jong Hoon Kim , Jeong-Hyung Lee , Seung Jun Kim
IPC分类号: C07C255/47 , C07C251/32 , C07C237/24 , C07C69/74 , C07D413/12 , C07D333/28 , C07D333/22 , C07D333/24 , C07D333/60 , C07D317/60 , C07D317/70 , C07D307/54 , C07D277/30 , C07D265/30 , C07D295/135 , C07D233/64 , C07D213/53 , C07D213/64 , A61K31/5377 , A61K31/495 , A61K31/4402 , A61K31/44 , A61K31/426 , A61K31/4164 , A61K31/381 , A61K31/36 , A61K31/277 , A61K31/216 , A61K31/165
CPC分类号: C07D213/30 , C07C291/02 , C07C309/66 , C07C2601/02 , C07C2601/14 , C07C2602/08 , C07C2603/74 , C07D213/53 , C07D233/64 , C07D277/24 , C07D295/088 , C07D295/185 , C07D307/54 , C07D317/60 , C07D317/70 , C07D333/24 , C07D333/28 , C07D417/12
摘要: An indene derivative for selectively modulating the activities of peroxisome proliferator activated receptors (PPARs) having the following formula (I): wherein, R1 is C1-6 alkyl, C1-6 alkenyl, or C3-6 cycloalkyl, each of which is unsubstituted or substituted with one or more phenyl groups; R2 is H, CN, CO2Ra, CH2CO2Ra, CONRbRc, or phenyl; R3 is C1-6 alkyl, C3-6 cycloalkyl, naphthyl, phenyl, being each unsubstituted or substituted with one or more substituents selected from the group consisting of halogen, CN, NH2, NO2, ORa, phenyloxy, C1-6 alkyl, and C3-6 cycloalkyl; and R4, R5, R6, and R7 are each independently H, OH, OSO2CH3, O(CH2)mRe, CH2Rf, OCOCH2ORg, OCH2CH2ORg, OCH2CH═CHRg, or pyridine-2-yloxy, or R5 and R6 together form OCH2O.
摘要翻译: 用于选择性调节具有下式(I)的过氧化物酶体增殖物激活受体(PPAR)的活性的茚衍生物:其中,R 1为C 1-6烷基,C 1-6链烯基或C 3-6环烷基,其各自为未取代或未取代的 被一个或多个苯基取代; R2是H,CN,CO2Ra,CH2CO2Ra,CONRbRc或苯基; R 3是C 1-6烷基,C 3-6环烷基,萘基,苯基,各自未被取代或被一个或多个选自卤素,CN,NH 2,NO 2,OR a,苯氧基,C 1-6烷基和 C3-6环烷基; 和R 4,R 5,R 6和R 7各自独立地为H,OH,OSO 2 CH 3,O(CH 2)m RE,CH 2 R f,OCOCH 2 OR g,OCH 2 CH 2 OR g,OCH 2 CH = CHR g或吡啶-2-基氧基,或者R 5和R 6一起形成OCH 2 O。
-
公开(公告)号:US20070225288A1
公开(公告)日:2007-09-27
申请号:US10599913
申请日:2005-04-12
申请人: Hyae Gyeong Cheon , Sung-Eun Yoo , Sung Soo Kim , Sung-Don Yang , Kwang-Rok Kim , Sang Dal Rhee , Jin Hee Ahn , Seung Kyu Kang , Won Hoon Jung , Sung Dae Park , Nam Gee Kim , Sun Mee Kim , Kil Woong Mo , Jae Mok Lee , Hye Jung Kang , Koun Ho Lee , Jong Hoon Kim , Jeong-Hyung Lee , Seung Jun Kim
发明人: Hyae Gyeong Cheon , Sung-Eun Yoo , Sung Soo Kim , Sung-Don Yang , Kwang-Rok Kim , Sang Dal Rhee , Jin Hee Ahn , Seung Kyu Kang , Won Hoon Jung , Sung Dae Park , Nam Gee Kim , Sun Mee Kim , Kil Woong Mo , Jae Mok Lee , Hye Jung Kang , Koun Ho Lee , Jong Hoon Kim , Jeong-Hyung Lee , Seung Jun Kim
IPC分类号: A61K31/216 , A61K31/4402 , A61K31/5375 , C07C69/753 , C07D211/70 , C07D265/32
CPC分类号: C07D295/088 , C07C65/26 , C07C69/757 , C07C229/50 , C07C233/52 , C07C255/47 , C07C2601/14 , C07C2602/08 , C07D295/155
摘要: The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.
摘要翻译: 式(I)的本发明的茚衍生物能够选择性调节过氧化物酶体增殖物激活受体(PPAR)的活性,不引起副作用,因此它们可用于治疗和预防由PPARs调节的病症, 糖尿病,肥胖,动脉硬化,高脂血症,高胰岛素血症和高血压等代谢综合征,骨质疏松症,肝硬化和哮喘等炎性疾病和癌症。
-
公开(公告)号:US5236935A
公开(公告)日:1993-08-17
申请号:US886986
申请日:1992-05-21
申请人: Sung-Eun Yoo , Kyu Y. Yi , Nak C. Jeong , Jee H. Suh , Seon-Ju Kim , Hwa-Sup Shin , Byung H. Lee , Kyu S. Jung
发明人: Sung-Eun Yoo , Kyu Y. Yi , Nak C. Jeong , Jee H. Suh , Seon-Ju Kim , Hwa-Sup Shin , Byung H. Lee , Kyu S. Jung
IPC分类号: C07D405/04
CPC分类号: C07D405/04
摘要: The present invention relates to novel benzopyran derivatives of formula (I) which have superior selectivity in the treatment of hypertension by lowering blood pressure with a relaxation activity on vascular smooth muscle. The present invention also relates to processes for preparing such compounds; and to a pharmaceutical compositions containing such compounds as an active ingredient. ##STR1## wherein: R.sub.1 is --CN, --NO.sub.2, --OCX.sub.1 X.sub.2 X.sub.3, --NH.sub.2, --NHSO.sub.2 R.sup.A, ##STR2## --SO.sub.2 R.sup.C or --SO.sub.2 NR.sup.C R.sup.D wherein X.sub.1, X.sub.2 and X.sub.3 are, each independently, a fluorine, chlorine or hydrogen atom; R.sup.A and R.sup.B are, each independently, an amino, C.sub.1-6 alkoxy, C.sub.1-6 alkyl group or an optionally substituted phenyl group; and R.sup.C and R.sup.D are a hydrogen atom, or a C.sub.1-6 alkyl group or an optionally substituted phenyl group with a halogen atom, or a straight or branched C.sub.1-3 alkyl group;R.sub.2 is ##STR3## wherein R.sup.E is a hydrogen atom, or a C.sub.1-6 alkyl, cyclopropyl, cyclopropylmethyl or benzyl group; R.sup.F is --COR.sup.A or --CSR.sup.A ; X is O, S or NR.sup.C, and n is an integer from 0 to 3, wherein R.sup.A and R.sup.C have the same meanings as defined above;R.sub.3 is a C.sub.1-4 straight or branched alkyl group; andR.sub.4 is ##STR4## wherein R.sup.G and R.sup.H are, each independently, a C.sub.-16 alkyl group or an optionally substituted phenyl group; A and B are, each independently, S or O; and Z is a C.sub.1-3 straight or branched alkyl group.
摘要翻译: 本发明涉及新型的式(I)的苯并吡喃衍生物,其通过降低血压以及对血管平滑肌的松弛活性而在治疗高血压方面具有优异的选择性。 本发明还涉及制备这些化合物的方法; 以及含有这些化合物作为活性成分的药物组合物。 (I)其中:R1是-CN,-NO2,-OCX1X2X3,-NH2,-NHSO2RA,-SO2RC或-SO2NRCRD,其中X1,X2和X3各自独立地是氟,氯或氢 原子; RA和RB各自独立地为氨基,C 1-6烷氧基,C 1-6烷基或任选取代的苯基; 和RC和RD是氢原子,或C 1-6烷基或任选取代的具有卤素原子的苯基,或直链或支链C 1-3烷基; R2是
其中RE是氢原子或C1-6烷基,环丙基,环丙基甲基或苄基; RF是-CORA或-CSRA; X是O,S或NRC,n是0-3的整数,其中RA和RC具有与上述相同的含义; R3是C1-4直链或支链烷基; 并且R 4是 ,其中RG和RH各自独立地是C 16-16烷基或任选取代的苯基; A和B各自独立地为S或O; Z为直链或支链的C1-3烷基。 -
公开(公告)号:US4880804A
公开(公告)日:1989-11-14
申请号:US142053
申请日:1988-01-07
IPC分类号: C07D235/08 , C07D235/16 , C07D403/12
CPC分类号: C07D403/12 , C07D235/08 , C07D235/16
摘要: Substituted benzimidazoles such as ##STR1## and pharmaceutically suitable salts thereof are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
摘要翻译: 取代的苯并咪唑如“IMAGE”及其药学上合适的盐可用作血管紧张素II阻断剂。 这些化合物具有治疗高血压和充血性心力衰竭的作用。
-
-
-